MSLE

SEC filing MSLE to Participate in Jefferies Global Healthcare Conference and Oppenheimer CNS & Neuro-Muscular Summit

6d ago

SEC filing MSLE Announces Annual General Meeting on June 17, 2026 to Elect Board, Appoint PwC as Auditors

13d ago

SEC filing MSLE Posts $9.8M Net Loss, $0.53 Loss/Share, $18.7M Cash, $70.7M Equity, $51.9M Financing Activity

18d ago

SEC filing MSLE Announces Satellos Presentation at Bloom Burton Healthcare Conference, CEO Frank Gleeson to Speak April 21

54d ago

SEC filing MSLE Reports Interim SAT-3247 Data, Shows Handgrip Strength Gains, Biomarker Reductions, FSHD Preclinical Strength, Enrollment Ongoing in TRAILHEAD BASECAMP

84d ago

SEC filing MSLE Announces Virtual KOL Event on SAT-3247 for DMD, Featuring Dr. Flanigan, Phase 2 Updates, TRAILHEAD & BASECAMP

103d ago

SEC filing MSLE Prices $57.2M Offering at $10.10, Lists on Nasdaq, Uses Proceeds for R&D

104d ago